150 related articles for article (PubMed ID: 29767993)
1. Multimetallic Microparticles Increase the Potency of Rifampicin against Intracellular Mycobacterium tuberculosis.
Ellis T; Chiappi M; García-Trenco A; Al-Ejji M; Sarkar S; Georgiou TK; Shaffer MSP; Tetley TD; Schwander S; Ryan MP; Porter AE
ACS Nano; 2018 Jun; 12(6):5228-5240. PubMed ID: 29767993
[TBL] [Abstract][Full Text] [Related]
2. Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition.
Lin W; Fan S; Liao K; Huang Y; Cong Y; Zhang J; Jin H; Zhao Y; Ruan Y; Lu H; Yang F; Wu C; Zhao D; Fu Z; Zheng B; Xu JF; Pi J
Front Cell Infect Microbiol; 2022; 12():1074533. PubMed ID: 36776549
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
Hakkimane SS; Shenoy VP; Gaonkar SL; Bairy I; Guru BR
Int J Nanomedicine; 2018; 13():4303-4318. PubMed ID: 30087562
[TBL] [Abstract][Full Text] [Related]
4. Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.
Choi SR; Britigan BE; Moran DM; Narayanasamy P
PLoS One; 2017; 12(5):e0177987. PubMed ID: 28542623
[TBL] [Abstract][Full Text] [Related]
5. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.
Clemens DL; Lee BY; Xue M; Thomas CR; Meng H; Ferris D; Nel AE; Zink JI; Horwitz MA
Antimicrob Agents Chemother; 2012 May; 56(5):2535-45. PubMed ID: 22354311
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy.
Tanner L; Mashabela GT; Omollo CC; de Wet TJ; Parkinson CJ; Warner DF; Haynes RK; Wiesner L
Microbiol Spectr; 2021 Oct; 9(2):e0043421. PubMed ID: 34585951
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal impact of Ag, ZnO and mixed AgZnO colloidal nanoparticles on H
Jafari A; Mosavari N; Movahedzadeh F; Nodooshan SJ; Safarkar R; Moro R; Kamalzadeh M; Majidpour A; Boustanshenas M; Mosavi T
Microb Pathog; 2017 Sep; 110():335-344. PubMed ID: 28710015
[TBL] [Abstract][Full Text] [Related]
8. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.
Carneiro SP; Carvalho KV; de Oliveira Aguiar Soares RD; Carneiro CM; de Andrade MHG; Duarte RS; Dos Santos ODH
Colloids Surf B Biointerfaces; 2019 Mar; 175():306-313. PubMed ID: 30553206
[TBL] [Abstract][Full Text] [Related]
9. Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis.
Andreu V; Larrea A; Rodriguez-Fernandez P; Alfaro S; Gracia B; Lucía A; Usón L; Gomez AC; Mendoza G; Lacoma A; Dominguez J; Prat C; Sebastian V; Ainsa JA; Arruebo M
Nanomedicine (Lond); 2019 Mar; 14(6):707-726. PubMed ID: 30734643
[TBL] [Abstract][Full Text] [Related]
10. A human xenobiotic nuclear receptor contributes to nonresponsiveness of
Bhagyaraj E; Tiwari D; Ahuja N; Nanduri R; Saini A; Kalra R; Kumar S; Janmeja AK; Gupta P
J Biol Chem; 2018 Mar; 293(10):3747-3757. PubMed ID: 29358328
[No Abstract] [Full Text] [Related]
11. An Overview of Various Rifampicin Analogs against
Asif M; Qusty NF; Alghamdi S
Med Chem; 2024; 20(3):268-292. PubMed ID: 37855280
[TBL] [Abstract][Full Text] [Related]
12. Toxicity effects of AgZnO nanoparticles and rifampicin on Mycobacterium tuberculosis into the macrophage.
Jafari A; Jafari Nodooshan S; Safarkar R; Movahedzadeh F; Mosavari N; Novin Kashani A; Dehghanpour M; Kamalzadeh M; Rasouli Koohi S; Fathizadeh S; Majidpour A
J Basic Microbiol; 2018 Jan; 58(1):41-51. PubMed ID: 29105782
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages.
Pati R; Sahu R; Panda J; Sonawane A
Sci Rep; 2016 Apr; 6():24184. PubMed ID: 27113139
[TBL] [Abstract][Full Text] [Related]
14. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
Vilchèze C; Kim J; Jacobs WR
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757
[TBL] [Abstract][Full Text] [Related]
16. Structural measurements and cell line studies of the copper-PEG-Rifampicin complex against Mycobacterium tuberculosis.
Manning T; Mikula R; Wylie G; Phillips D; Jarvis J; Zhang F
Bioorg Med Chem Lett; 2015 Feb; 25(3):451-8. PubMed ID: 25575660
[TBL] [Abstract][Full Text] [Related]
17. Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.
D'Addio SM; Reddy VM; Liu Y; Sinko PJ; Einck L; Prud'homme RK
Mol Pharm; 2015 May; 12(5):1554-63. PubMed ID: 25811733
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
19. Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish.
Vibe CB; Fenaroli F; Pires D; Wilson SR; Bogoeva V; Kalluru R; Speth M; Anes E; Griffiths G; Hildahl J
Nanotoxicology; 2016 Aug; 10(6):680-8. PubMed ID: 26573343
[TBL] [Abstract][Full Text] [Related]
20. An Overview of Zinc Oxide Nanoparticles Produced by Plant Extracts for Anti-tuberculosis Treatments.
Behzad F; Sefidgar E; Samadi A; Lin W; Pouladi I; Pi J
Curr Med Chem; 2022; 29(1):86-98. PubMed ID: 34126883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
